BTIG upgraded DexCom (NASDAQ: DXCM) from Neutral to Buy with a price target of $92. Analyst Sean Lavin sees an ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE